Exposure to abatacept or rituximab in the first trimester of pregnancy in three women with autoimmune diseases (Q33405115)

26 July 2017

title

Exposure to abatacept or rituximab in the first trimester of pregnancy in three women with autoimmune diseases (English)

1 reference

26 July 2017

1 reference

1 reference

Mario Ojeda-Uribe

1

0 references

author name string

Naji Afif

2

1 reference

26 July 2017

Etienne Dahan

3

1 reference

26 July 2017

Laetitia Sparsa

4

1 reference

26 July 2017

Celine Haby

5

1 reference

26 July 2017

Jean Sibilia

6

1 reference

26 July 2017

David Ternant

7

1 reference

26 July 2017

Marc Ardizzone

8

1 reference

26 July 2017

publication date

5 January 2013

1 reference

26 July 2017

published in

Clinical Rheumatology

1 reference

26 July 2017

volume

32

1 reference

26 July 2017

issue

5

1 reference

26 July 2017

page(s)

695-700

1 reference

B-cell targeting in rheumatoid arthritis and other autoimmune diseases

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Dynamics of immunoglobulins at the feto-maternal interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

An IgG-transporting Fc receptor expressed in the syncytiotrophoblast of human placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

FcRn: the MHC class I-related receptor that is more than an IgG transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Pregnancy outcomes after maternal exposure to rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Cytokines and T cells in host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

The pathogenesis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Abatacept therapy and safety management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Biologic agents for rheumatoid arthritis--negotiating the NICE technology appraisals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Disparities in Rates of Unintended Pregnancy In the United States, 1994 and 2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

The double life of a B-1 cell: self-reactivity selects for protective effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Rheumatoid arthritis and pregnancy: safety considerations in pharmacological management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Treatment with biologics of pregnant patients with rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Quantitative abnormalities of peripheral blood distinct T, B, and natural killer cell subsets and clinical findings in obstetric antiphospholipid syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

The role of gender and organ specific autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Pharmacokinetics of rituximab and its clinical use: thought for the best use?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Biologic therapy and pregnancy outcomes in women with rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Rituximab administration in third trimester of pregnancy suppresses neonatal B-cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: impact of withdrawal and reintroduction on immunogenicity, efficacy and safety (phase Iiib ALLOW study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2156-4

Population pharmacokinetics of rituximab (anti-CD20 monoclonal antibody) in rheumatoid arthritis patients during a phase II clinical trial

21 January 2018

1 reference

12 December 2020

Administration of rituximab during the first trimester of pregnancy without consequences for the newborn

1 reference

12 December 2020

Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20.

1 reference

12 December 2020

Changes in T, B, and NK lymphocyte subsets during and after normal pregnancy

1 reference

12 December 2020

Human CD5+ B lymphocytes (B-1 cells) decrease in peripheral blood during pregnancy

1 reference

12 December 2020

Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset

1 reference

12 December 2020

Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: implications for maternal-fetal antibody transport.

1 reference

12 December 2020

Rituximab (MabThera) therapy and safety management. Clinical tool guide

1 reference

12 December 2020

IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma

1 reference

12 December 2020

Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy

1 reference

12 December 2020

Successful long-term rituximab maintenance for a relapsing patient with idiopathic thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig

1 reference

12 December 2020

The effects of rituximab treatment during pregnancy on a neonate

1 reference

12 December 2020

Disparities in rates of unintended pregnancy in the United States, 1994 and 2001

1 reference

12 December 2020

10.1007/S10067-012-2156-4

Identifiers

DOI

1 reference

26 July 2017

1 reference